FDA Targeting Execs With Criminal Charges For Adulterated/Misbranded Goods
This article was originally published in The Rose Sheet
Executive Summary
FDA increasingly will prosecute corporate officers in response to criticism over the agency's handling of violations of the Federal Food, Drug & Cosmetic Act in recent years